OAS2

This gene encodes a member of the 2-5A synthetase family, essential proteins involved in the innate immune response to viral infection. The encoded protein is induced by interferons and uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactions to synthesize 2',5'-oligoadenylates (2-5As). These molecules activate latent RNase L, which results in viral RNA degradation and the inhibition of viral replication. Diseases associated with OAS2 include Microphthalmia With Limb Anomalies. Among its related pathways are Cytokine Signaling in Immune system and Innate Immune System.
Full Name
2'-5'-oligoadenylate synthetase 2
Function
Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response (PubMed:10464285, PubMed:9880569).
Activated by detection of double stranded RNA (dsRNA): polymerizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNASEL) leading to its dimerization and subsequent activation (PubMed:10464285, PubMed:9880569, PubMed:11682059).
Activation of RNASEL leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication (PubMed:10464285, PubMed:9880569).
Can mediate the antiviral effect via the classical RNASEL-dependent pathway or an alternative antiviral pathway independent of RNASEL (PubMed:21142819).
In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation (PubMed:21142819).
May act as a negative regulator of lactation, stopping lactation in virally infected mammary gland lobules, thereby preventing transmission of viruses to neonates (By similarity).
Non-infected lobules would not be affected, allowing efficient pup feeding during infection (By similarity).
Biological Process
Defense response to bacteriumManual Assertion Based On ExperimentIMP:ARUK-UCL
Defense response to virusISS:UniProtKB
Interleukin-27-mediated signaling pathwayManual Assertion Based On ExperimentIDA:ARUK-UCL
Negative regulation of viral genome replicationManual Assertion Based On ExperimentIBA:GO_Central
Nucleobase-containing compound metabolic processManual Assertion Based On ExperimentTAS:ProtInc
Positive regulation of interferon-beta productionManual Assertion Based On ExperimentIMP:ARUK-UCL
Positive regulation of tumor necrosis factor productionManual Assertion Based On ExperimentIMP:ARUK-UCL
Regulation of lactationISS:UniProtKB
Regulation of ribonuclease activityManual Assertion Based On ExperimentIBA:GO_Central
Response to virusManual Assertion Based On ExperimentTAS:UniProtKB
RNA catabolic processIEA:Ensembl
Type I interferon signaling pathwayISS:UniProtKB
Cellular Location
Cytoplasm
Cytoplasm, perinuclear region
PTM
Myristoylation is not essential for its activity.
Glycosylated. Glycosylation is essential for its activity.
View more

Anti-OAS2 antibodies

+ Filters
Loading...
Target: OAS2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBXO-0508
Application*: IP, IC
Target: OAS2
Host: Mouse
Specificity: Mouse, Rat, Human
Clone: CBXO-0350
Application*: WB, IP, IF, P, E
Target: OAS2
Host: Mouse
Specificity: Human
Clone: CBXO-0316
Application*: WB, IP, IF, E
Target: OAS2
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 3D4
Application*: WB
Target: OAS2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 2A1
Application*: WB
Target: OAS2
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 4B11
Application*: WB
Target: OAS2
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 5E1
Application*: P, WB
More Infomation
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
  • AActivation
  • AGAgonist
  • APApoptosis
  • BBlocking
  • BABioassay
  • BIBioimaging
  • CImmunohistochemistry-Frozen Sections
  • CIChromatin Immunoprecipitation
  • CTCytotoxicity
  • CSCostimulation
  • DDepletion
  • DBDot Blot
  • EELISA
  • ECELISA(Cap)
  • EDELISA(Det)
  • ESELISpot
  • EMElectron Microscopy
  • FFlow Cytometry
  • FNFunction Assay
  • GSGel Supershift
  • IInhibition
  • IAEnzyme Immunoassay
  • ICImmunocytochemistry
  • IDImmunodiffusion
  • IEImmunoelectrophoresis
  • IFImmunofluorescence
  • IHImmunohistochemistry
  • IMImmunomicroscopy
  • IOImmunoassay
  • IPImmunoprecipitation
  • ISIntracellular Staining for Flow Cytometry
  • LALuminex Assay
  • LFLateral Flow Immunoassay
  • MMicroarray
  • MCMass Cytometry/CyTOF
  • MDMeDIP
  • MSElectrophoretic Mobility Shift Assay
  • NNeutralization
  • PImmunohistologyp-Paraffin Sections
  • PAPeptide Array
  • PEPeptide ELISA
  • PLProximity Ligation Assay
  • RRadioimmunoassay
  • SStimulation
  • SESandwich ELISA
  • SHIn situ hybridization
  • TCTissue Culture
  • WBWestern Blot
online inquiry
Online Inquiry